Since ENO1 antibodies have been proposed as a drug in cancers and autoimmune diseases [71], in regard to EV-A71 antiviral therapy, ENO1 targeting might be a therapeutic strategy for preventing severe disease of EV-A71 infection. This evidence concerns the gene ENO1 and cancer.